Reuters logo
BRIEF-Adamas Pharmaceuticals completes phase 1 clinical trial of ADS-4101 for treatment of partial onset seizures in patients with epilepsy
January 3, 2017 / 10:33 PM / 9 months ago

BRIEF-Adamas Pharmaceuticals completes phase 1 clinical trial of ADS-4101 for treatment of partial onset seizures in patients with epilepsy

Jan 3 (Reuters) - Adamas Pharmaceuticals Inc :

* Adamas Pharmaceuticals completes phase 1 clinical trial of ads-4101 for treatment of partial onset seizures in patients with epilepsy

* Adamas Pharmaceuticals Inc - “we are encouraged by results of this phase 1 clinical trial in ADS-4101 and look forward to advancing program in 2017” Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below